Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KNSA |
---|---|---|
09:32 ET | 2662 | 19.415 |
09:34 ET | 400 | 19.16 |
09:36 ET | 100 | 19.16 |
09:38 ET | 200 | 19.215 |
09:41 ET | 100 | 19.27 |
09:43 ET | 100 | 19.27 |
09:45 ET | 2400 | 19.36 |
09:54 ET | 550 | 19.25 |
09:56 ET | 100 | 19.245 |
10:01 ET | 100 | 19.315 |
10:08 ET | 100 | 19.34 |
10:17 ET | 227 | 19.31 |
10:19 ET | 100 | 19.32 |
10:21 ET | 600 | 19.32 |
10:35 ET | 100 | 19.34 |
10:37 ET | 100 | 19.33 |
10:39 ET | 206 | 19.365 |
10:46 ET | 100 | 19.35 |
10:48 ET | 502 | 19.37 |
10:50 ET | 200 | 19.35 |
10:53 ET | 7801 | 19.39 |
10:57 ET | 100 | 19.39 |
11:04 ET | 8638 | 19.47 |
11:09 ET | 100 | 19.475 |
11:11 ET | 100 | 19.49 |
11:13 ET | 100 | 19.505 |
11:15 ET | 300 | 19.49 |
11:20 ET | 200 | 19.48 |
11:26 ET | 100 | 19.5 |
11:33 ET | 1321 | 19.5167 |
11:36 ET | 200 | 19.5 |
11:40 ET | 100 | 19.48 |
11:44 ET | 100 | 19.46 |
11:49 ET | 100 | 19.47 |
11:51 ET | 378 | 19.43 |
11:54 ET | 200 | 19.405 |
11:56 ET | 100 | 19.41 |
12:02 ET | 224 | 19.42 |
12:05 ET | 200 | 19.43 |
12:07 ET | 100 | 19.43 |
12:12 ET | 200 | 19.4 |
12:16 ET | 100 | 19.39 |
12:23 ET | 500 | 19.38 |
12:25 ET | 100 | 19.4 |
12:30 ET | 100 | 19.395 |
12:43 ET | 200 | 19.4 |
12:48 ET | 100 | 19.41 |
12:50 ET | 200 | 19.41 |
12:54 ET | 100 | 19.43 |
12:56 ET | 118 | 19.43 |
12:57 ET | 1150 | 19.4 |
12:59 ET | 500 | 19.37 |
01:06 ET | 100 | 19.345 |
01:10 ET | 100 | 19.34 |
01:12 ET | 1300 | 19.35 |
01:24 ET | 100 | 19.4 |
01:26 ET | 115 | 19.3822 |
01:28 ET | 400 | 19.37 |
01:30 ET | 100 | 19.38 |
01:35 ET | 403 | 19.32 |
01:37 ET | 300 | 19.33 |
01:44 ET | 100 | 19.3 |
01:55 ET | 120 | 19.275 |
01:57 ET | 300 | 19.27 |
02:06 ET | 700 | 19.23 |
02:11 ET | 100 | 19.22 |
02:15 ET | 117 | 19.22 |
02:18 ET | 100 | 19.23 |
02:26 ET | 100 | 19.23 |
02:31 ET | 100 | 19.22 |
02:33 ET | 100 | 19.2 |
02:36 ET | 100 | 19.19 |
02:42 ET | 208 | 19.17 |
02:45 ET | 1314 | 19.17 |
02:47 ET | 357 | 19.165 |
02:54 ET | 100 | 19.14 |
02:56 ET | 100 | 19.135 |
03:02 ET | 600 | 19.15 |
03:03 ET | 100 | 19.15 |
03:05 ET | 100 | 19.15 |
03:09 ET | 1332 | 19.13 |
03:12 ET | 100 | 19.12 |
03:14 ET | 200 | 19.13 |
03:16 ET | 360 | 19.125 |
03:20 ET | 200 | 19.14 |
03:21 ET | 640 | 19.13 |
03:23 ET | 100 | 19.13 |
03:25 ET | 500 | 19.15 |
03:30 ET | 100 | 19.13 |
03:32 ET | 100 | 19.13 |
03:34 ET | 200 | 19.13 |
03:38 ET | 1600 | 19.14 |
03:39 ET | 100 | 19.14 |
03:41 ET | 459 | 19.15 |
03:43 ET | 800 | 19.12 |
03:45 ET | 600 | 19.11 |
03:48 ET | 2700 | 19.1 |
03:50 ET | 227 | 19.1 |
03:52 ET | 1500 | 19.11 |
03:54 ET | 1010 | 19.13 |
03:56 ET | 3433 | 19.07 |
03:57 ET | 2885 | 19.06 |
03:59 ET | 4132 | 19.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.4B | 223.6x | --- |
Ginkgo Bioworks Holdings Inc | 1.5B | -1.5x | --- |
Dynavax Technologies Corp | 1.5B | 228.0x | --- |
Zai Lab Ltd | 1.8B | -5.1x | --- |
BioCryst Pharmaceuticals Inc | 1.3B | -5.7x | --- |
MannKind Corp | 1.3B | 204.0x | --- |
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $301.8M |
Shares Outstanding | 70.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.33 |
EPS | $0.09 |
Book Value | $6.23 |
P/E Ratio | 223.6x |
Price/Sales (TTM) | 4.5 |
Price/Cash Flow (TTM) | 124.4x |
Operating Margin | -10.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.